Doug Hampton

CymaBay Therapeutics Presents Data Showing Seladelpar Treatment in Primary Biliary Cholangitis (PBC) Correlates with Alleviation of Self-Reported Pruritus and Reduction in Serum IL-31 Levels

by

Additional data presented at The International Liver Congress™ 2023 show clinical risk factors for PBC disease progression present in a broader population of UDCA-treated PBC patients Preclinical data points to need for the study of novel pathways mediated by seladelpar and their role in reducing fibrosis NEWARK, Calif., June 21, 2023 /PRNewswire/ — CymaBay Therapeutics, … Read more

UNION therapeutics announces positive topline results from the OSIRIS investigator-initiated proof-of-concept study of oral orismilast in patients with hidradenitis suppurativa

by

Study demonstrates clinically relevant improvements in patients with hidradenitis suppurativa (HS) receiving 16 weeks of treatment with oral orismilast Study supports the dose-finding results from the recent IASOS Phase 2b study of oral orismilast in psoriasis Orismilast has been granted a Fast Track designation by the FDA for HS, and UNION plans to seek regulatory … Read more

Novo Holdings to acquire Ellab

by

COPENHAGEN, Denmark, June 21, 2023 /PRNewswire/ — Novo Holdings A/S, a leading global life sciences investor, today announced that it has agreed to acquire Ellab from EQT. Headquartered in Hillerød, Denmark, Ellab (“Ellab”) provides validation and monitoring solutions and services for biotech and pharmaceutical processes. Its solutions and services measure and document parameters such as temperature, … Read more

UNION therapeutics announces positive topline results from the OSIRIS investigator-initiated proof-of-concept study of oral orismilast in patients with hidradenitis suppurativa USA – English USA – English

by

Study demonstrates clinically relevant improvements in patients with hidradenitis suppurativa (HS) receiving 16 weeks of treatment with oral orismilast Study supports the dose-finding results from the recent IASOS Phase 2b study of oral orismilast in psoriasis Orismilast has been granted a Fast Track designation by the FDA for HS, and UNION plans to seek regulatory … Read more

Reduction of health expenditure: LFI and the PS criticize the announcements of Bercy

by

the essential The left in the National Assembly strongly criticizes the government which targets health expenditure (drugs and sick leave) to save money. The leader of the LFI deputies Mathilde Panot on Tuesday denounced the “social abuse” and the “brutality” of the government’s announcements to reduce health spending, in unison with the Socialists, auguring heated … Read more

Explosion of work stoppages: how thousands of doctors will be checked by Health Insurance

by

the essential Faced with the explosion in the number of work stoppages, the Health Insurance has launched a new campaign to control attending physicians. For the doctors’ unions, it is neither more nor less than a “witch hunt”: Health Insurance last week launched a wave of checks to “fight against the excesses” of certain doctors, … Read more

Explosion of work stoppages: teleconsultation in the sights of doctors’ unions

by

the essential While the number of work stoppages is exploding, teleconsultation – these cabins allowing patients to obtain medical advice by videoconference – worries general practitioners, who believe that these devices, without supervision, “discredit the profession” and cause flames the number of prescriptions. You might have seen one when you went to your pharmacist: teleconsultation … Read more

Interius BioTherapeutics Highlights Strong Preclinical Data Supporting In Vivo Chimeric Antigen Receptor (CAR) Vector Evaluation in Clinic

by

Lead candidate demonstrates specificity, biologic activity and a favorable safety profile in extensive mouse and non-human primate models Upcoming company presentations at Cellicon Valley ’23 and In Vivo Engineering of Therapeutic Cells Summit PHILADELPHIA, June 21, 2023 /PRNewswire/ — Interius BioTherapeutics, a leading developer of in vivo cell-specific genetic medicine therapeutics, today announced the presentation of compelling … Read more